Metadata
Author: springer
Data
German[de]
B. Cilengitid, Enzastaurin, Temsirolimus, Cediranib, Epidermal-Growth-Factor-Receptor- (EGFR-)Inhibitoren oder der monoklonale Vascular-Endothelial-Growth-Factor- (VEGF-)Antikörper Bevacizumab werden als Monotherapie im Rezidiv und in den genannten Kombinationen in der Primärtherapie untersucht.
English[en]
Compounds, such as cilengitide, enzastaurin, temsirolimus, cediranib, epidermal growth factor receptor (EGFR) inhibitors or the monoclonal anti-vascular endothelial growth factor (VEGF) antibody bevacizumab are being assessed as monotherapy for recurrence of malignant gliomas or in combination with radiotherapy or radiochemotherapy with temozolomide.